Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in ...

Delve into bronchiectasis, a field long focused on managing symptoms that now has its first targeted treatment with ...

Delve into Roche's strategy, a company originally built on oncology, now reinventing its pipeline in obesity and immunology.

Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...

Discover why animal models fall short in AI drug discovery and how human-first datasets and functional genomics are changing ...

California-based Cargo Therapeutics has had a rough year with its CAR-T cell therapy firicabtagene autoleucel being discontinued after patients experienced toxic side effects in the clinic. The ...

For people living with sickle cell disease, it means facing lifelong challenges marked by episodes of severe pain, fatigue, and frequent medical visits. This is because the inherited blood disorder, ...

Home to the European Commission (EC), Belgium holds a reputation for life sciences and innovation in Europe. In the port city of Ghent, the Vlaams Instituut voor Biotechnologie (VIB) wants to bridge ...

Despite decades of progress in oncology, the majority of cancer drugs that enter clinical trials never reach the market and the patients who need them most. Late-stage failure remains one of the most ...